申请人:BRISTOL-MYERS SQUIBB COMPANY
公开号:US20160200710A1
公开(公告)日:2016-07-14
Disclosed are compounds of Formula (I); and salts thereof, wherein: Formula (II); Q is: R
1
is —C(CH
3
)2OH, —NHC(=0)C(CH
3
)
3
, —N(CH3)2, or —CH
2
R
d
; R
2
is CI or —CH
3
; R
3
is H, F, or —CH
3
; R
a
is H or —CH
3
; R
b
is H, F, CI, or —OCH3 R
c
is H or F; and Rd is —OH, —OCH3, —NHC(=0)CH3, or fORMULA (III), Also disclosed are methods of using such compounds as inhibitors of Bruton's tyrosine kinase (Btk), and pharmaceutical compositions comprising such compounds. These compounds are useful in treating, preventing, or slowing the progression of diseases or disorders in a variety of therapeutic areas, such as autoimmune diseases and vascular disease.
本发明涉及式(I)化合物及其盐,其中:式(II);Q为:R1为—C(CH3)2OH,—NHC(=0)C(CH3)3,—N(CH3)2或—CH2Rd;R2为CI或—CH3;R3为H,F或—CH3;Ra为H或—CH3;Rb为H,F,CI或—OCH3;Rc为H或F;Rd为—OH,—OCH3,—NHC(=0)CH3或式(III),还公开了使用这些化合物作为Bruton酪氨酸激酶(Btk)抑制剂的方法以及包含这些化合物的制药组合物。这些化合物在多种治疗领域中,如自身免疫疾病和血管疾病中,用于治疗、预防或减缓疾病或疾病的进展。